Thymoquinone loaded nanoemulgel in streptozotocin induced diabetic wound
Aim: To treat diabetic wound healing with a novel Thymoquinone (TQ) loaded nanoformulation by using combination of essentials oils. Methods: TQ nanoemulsion (NE) was developed with seabuckthorn & lavender essential oils by phase inversion method and mixture design. Further, DIAGEL is obtained by...
Gespeichert in:
Hauptverfasser: | , , , , , , , |
---|---|
Format: | Dataset |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | Anuradha, Urati Bhavana, Valamla Chary, Padakanti Sandeep Rajana, Naveen Parida, Kishan Kumar Kalia, Nitin Pal Khatri, Dharmendra Kumar Mehra, Neelesh Kumar |
description | Aim: To treat diabetic wound healing with a novel Thymoquinone (TQ) loaded nanoformulation by using combination of essentials oils. Methods: TQ nanoemulsion (NE) was developed with seabuckthorn & lavender essential oils by phase inversion method and mixture design. Further, DIAGEL is obtained by incorporating NE into 1% carbopol®934. Furthermore, particle size, polydispersity index, thermodynamic stability studies, rheology, spreadability, drug content, in-vitro drug release, ex-vivo permeation, anti-oxidant assay, antimicrobial studies, angioirritance, HAT-CAM assay, in-vitro and in-vivo studies were determined. Results: NE has a particle size of 17.79 ± 0.61 nm, 0.206 ± 0.012 PDI & found to be thermodynamically stable. DIAGEL exhibited pseudoplastic behavior, sustained drug release, better permeation of TQ and a drug content of 98.54 ± 0.08%. DIAGEL stored for 6 months at room temperature and 2–8°C showed no degradation. Further, an improved angiogenesis, absence of angio-irritancy, remarkable antioxidant and antimicrobial activities against Candida albicans & S. aureus were observed. Cytotoxicity analysis revealed nearly 2.28 -folds higher IC50 value than drug solution. Furthermore, inflammatory mediators were reduced in DIAGEL treated animal groups. The histopathological studies confirmed skin healing with regeneration and granulation of tissue. Conclusion: The novel formulation has strong anti-inflammatory, angiogenesis, antioxidant and appreciable diabetic wound healing properties. Diabetic foot ulcer is a skin-inflammatory disease condition characterized by high blood glucose levels, & poor wound healing affecting mostly diabetic patients. Thymoquinone is a natural compound with anti-oxidant, anti-microbial, & anti-inflammatory, low solubility makes it challenging for formulation development. Nanoemulgel containing combination of oils with high solubility of thymoquinone can be an ideal one. We employed pseudo ternary phase diagram for selection of Smix ratio for developing annaoemlusion and to optimize the nanoemulsion we used here Randomized I-optimal mixture design, for characterization of nanoemulsion and nanoemulgel we used TEM, for gel properties we used here rheometer and texture analyzer. Developed nanoemulgel shows remarkable in-vitro antimicrobial activity against Candida albicans and S. aureus & also stimulating angiogenesis & negligible angioirritation by CAM assay. In-vitro cell lines studies were conducted on L929 cell to check the cyt |
doi_str_mv | 10.6084/m9.figshare.27878226 |
format | Dataset |
fullrecord | <record><control><sourceid>datacite_PQ8</sourceid><recordid>TN_cdi_datacite_primary_10_6084_m9_figshare_27878226</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_6084_m9_figshare_27878226</sourcerecordid><originalsourceid>FETCH-datacite_primary_10_6084_m9_figshare_278782263</originalsourceid><addsrcrecordid>eNqdzk0OgjAUBOBuXBj1Bi56ARGQ8LM2Gg7Avqn0AS9p-7C0MXh6MZELuJpMMpN8jB2TOMrjMjubKuqwnwbpIEqLsijTNN-yuhlmQ8-AlixwTVKB4lZaAhN0D5qj5ZN3MHp6k6d2qWhVaJeVQvkAjy1_UbBqzzad1BMcfrlj2f3WXOuTkl626EGMDo10s0hi8QUJU4kVJFbQ5c_bBwK3Suw</addsrcrecordid><sourcetype>Publisher</sourcetype><iscdi>true</iscdi><recordtype>dataset</recordtype></control><display><type>dataset</type><title>Thymoquinone loaded nanoemulgel in streptozotocin induced diabetic wound</title><source>DataCite</source><creator>Anuradha, Urati ; Bhavana, Valamla ; Chary, Padakanti Sandeep ; Rajana, Naveen ; Parida, Kishan Kumar ; Kalia, Nitin Pal ; Khatri, Dharmendra Kumar ; Mehra, Neelesh Kumar</creator><creatorcontrib>Anuradha, Urati ; Bhavana, Valamla ; Chary, Padakanti Sandeep ; Rajana, Naveen ; Parida, Kishan Kumar ; Kalia, Nitin Pal ; Khatri, Dharmendra Kumar ; Mehra, Neelesh Kumar</creatorcontrib><description><![CDATA[Aim: To treat diabetic wound healing with a novel Thymoquinone (TQ) loaded nanoformulation by using combination of essentials oils. Methods: TQ nanoemulsion (NE) was developed with seabuckthorn & lavender essential oils by phase inversion method and mixture design. Further, DIAGEL is obtained by incorporating NE into 1% carbopol®934. Furthermore, particle size, polydispersity index, thermodynamic stability studies, rheology, spreadability, drug content, in-vitro drug release, ex-vivo permeation, anti-oxidant assay, antimicrobial studies, angioirritance, HAT-CAM assay, in-vitro and in-vivo studies were determined. Results: NE has a particle size of 17.79 ± 0.61 nm, 0.206 ± 0.012 PDI & found to be thermodynamically stable. DIAGEL exhibited pseudoplastic behavior, sustained drug release, better permeation of TQ and a drug content of 98.54 ± 0.08%. DIAGEL stored for 6 months at room temperature and 2–8°C showed no degradation. Further, an improved angiogenesis, absence of angio-irritancy, remarkable antioxidant and antimicrobial activities against Candida albicans & S. aureus were observed. Cytotoxicity analysis revealed nearly 2.28 -folds higher IC50 value than drug solution. Furthermore, inflammatory mediators were reduced in DIAGEL treated animal groups. The histopathological studies confirmed skin healing with regeneration and granulation of tissue. Conclusion: The novel formulation has strong anti-inflammatory, angiogenesis, antioxidant and appreciable diabetic wound healing properties. Diabetic foot ulcer is a skin-inflammatory disease condition characterized by high blood glucose levels, & poor wound healing affecting mostly diabetic patients. Thymoquinone is a natural compound with anti-oxidant, anti-microbial, & anti-inflammatory, low solubility makes it challenging for formulation development. Nanoemulgel containing combination of oils with high solubility of thymoquinone can be an ideal one. We employed pseudo ternary phase diagram for selection of Smix ratio for developing annaoemlusion and to optimize the nanoemulsion we used here Randomized I-optimal mixture design, for characterization of nanoemulsion and nanoemulgel we used TEM, for gel properties we used here rheometer and texture analyzer. Developed nanoemulgel shows remarkable in-vitro antimicrobial activity against Candida albicans and S. aureus & also stimulating angiogenesis & negligible angioirritation by CAM assay. In-vitro cell lines studies were conducted on L929 cell to check the cytotoxicity of developed nanoformulation and also to check the cellular internalization, ROS, morphology, migration assay and apoptosis. In diabetic wound animal model nanoemulgel showed significant decreased levels of TNF-α, IL-6, MMP-9 and IL-1β. Histopathological studies also showed that absence of inflammatory cells, and granulation of tissue was seen. The amalgamation of these data strongly suggests that the nanoemulgel is a possible strategy for drug-delivery systems, with significant promising for the management of diabetic wound.]]></description><identifier>DOI: 10.6084/m9.figshare.27878226</identifier><language>eng</language><publisher>Taylor & Francis</publisher><subject>Biochemistry ; Biotechnology ; Cancer ; Chemical Sciences not elsewhere classified ; Developmental Biology ; FOS: Clinical medicine ; FOS: Health sciences ; Immunology ; Infectious Diseases ; Medicine</subject><creationdate>2024</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>780,1894</link.rule.ids><linktorsrc>$$Uhttps://commons.datacite.org/doi.org/10.6084/m9.figshare.27878226$$EView_record_in_DataCite.org$$FView_record_in_$$GDataCite.org$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Anuradha, Urati</creatorcontrib><creatorcontrib>Bhavana, Valamla</creatorcontrib><creatorcontrib>Chary, Padakanti Sandeep</creatorcontrib><creatorcontrib>Rajana, Naveen</creatorcontrib><creatorcontrib>Parida, Kishan Kumar</creatorcontrib><creatorcontrib>Kalia, Nitin Pal</creatorcontrib><creatorcontrib>Khatri, Dharmendra Kumar</creatorcontrib><creatorcontrib>Mehra, Neelesh Kumar</creatorcontrib><title>Thymoquinone loaded nanoemulgel in streptozotocin induced diabetic wound</title><description><![CDATA[Aim: To treat diabetic wound healing with a novel Thymoquinone (TQ) loaded nanoformulation by using combination of essentials oils. Methods: TQ nanoemulsion (NE) was developed with seabuckthorn & lavender essential oils by phase inversion method and mixture design. Further, DIAGEL is obtained by incorporating NE into 1% carbopol®934. Furthermore, particle size, polydispersity index, thermodynamic stability studies, rheology, spreadability, drug content, in-vitro drug release, ex-vivo permeation, anti-oxidant assay, antimicrobial studies, angioirritance, HAT-CAM assay, in-vitro and in-vivo studies were determined. Results: NE has a particle size of 17.79 ± 0.61 nm, 0.206 ± 0.012 PDI & found to be thermodynamically stable. DIAGEL exhibited pseudoplastic behavior, sustained drug release, better permeation of TQ and a drug content of 98.54 ± 0.08%. DIAGEL stored for 6 months at room temperature and 2–8°C showed no degradation. Further, an improved angiogenesis, absence of angio-irritancy, remarkable antioxidant and antimicrobial activities against Candida albicans & S. aureus were observed. Cytotoxicity analysis revealed nearly 2.28 -folds higher IC50 value than drug solution. Furthermore, inflammatory mediators were reduced in DIAGEL treated animal groups. The histopathological studies confirmed skin healing with regeneration and granulation of tissue. Conclusion: The novel formulation has strong anti-inflammatory, angiogenesis, antioxidant and appreciable diabetic wound healing properties. Diabetic foot ulcer is a skin-inflammatory disease condition characterized by high blood glucose levels, & poor wound healing affecting mostly diabetic patients. Thymoquinone is a natural compound with anti-oxidant, anti-microbial, & anti-inflammatory, low solubility makes it challenging for formulation development. Nanoemulgel containing combination of oils with high solubility of thymoquinone can be an ideal one. We employed pseudo ternary phase diagram for selection of Smix ratio for developing annaoemlusion and to optimize the nanoemulsion we used here Randomized I-optimal mixture design, for characterization of nanoemulsion and nanoemulgel we used TEM, for gel properties we used here rheometer and texture analyzer. Developed nanoemulgel shows remarkable in-vitro antimicrobial activity against Candida albicans and S. aureus & also stimulating angiogenesis & negligible angioirritation by CAM assay. In-vitro cell lines studies were conducted on L929 cell to check the cytotoxicity of developed nanoformulation and also to check the cellular internalization, ROS, morphology, migration assay and apoptosis. In diabetic wound animal model nanoemulgel showed significant decreased levels of TNF-α, IL-6, MMP-9 and IL-1β. Histopathological studies also showed that absence of inflammatory cells, and granulation of tissue was seen. The amalgamation of these data strongly suggests that the nanoemulgel is a possible strategy for drug-delivery systems, with significant promising for the management of diabetic wound.]]></description><subject>Biochemistry</subject><subject>Biotechnology</subject><subject>Cancer</subject><subject>Chemical Sciences not elsewhere classified</subject><subject>Developmental Biology</subject><subject>FOS: Clinical medicine</subject><subject>FOS: Health sciences</subject><subject>Immunology</subject><subject>Infectious Diseases</subject><subject>Medicine</subject><fulltext>true</fulltext><rsrctype>dataset</rsrctype><creationdate>2024</creationdate><recordtype>dataset</recordtype><sourceid>PQ8</sourceid><recordid>eNqdzk0OgjAUBOBuXBj1Bi56ARGQ8LM2Gg7Avqn0AS9p-7C0MXh6MZELuJpMMpN8jB2TOMrjMjubKuqwnwbpIEqLsijTNN-yuhlmQ8-AlixwTVKB4lZaAhN0D5qj5ZN3MHp6k6d2qWhVaJeVQvkAjy1_UbBqzzad1BMcfrlj2f3WXOuTkl626EGMDo10s0hi8QUJU4kVJFbQ5c_bBwK3Suw</recordid><startdate>20241121</startdate><enddate>20241121</enddate><creator>Anuradha, Urati</creator><creator>Bhavana, Valamla</creator><creator>Chary, Padakanti Sandeep</creator><creator>Rajana, Naveen</creator><creator>Parida, Kishan Kumar</creator><creator>Kalia, Nitin Pal</creator><creator>Khatri, Dharmendra Kumar</creator><creator>Mehra, Neelesh Kumar</creator><general>Taylor & Francis</general><scope>DYCCY</scope><scope>PQ8</scope></search><sort><creationdate>20241121</creationdate><title>Thymoquinone loaded nanoemulgel in streptozotocin induced diabetic wound</title><author>Anuradha, Urati ; Bhavana, Valamla ; Chary, Padakanti Sandeep ; Rajana, Naveen ; Parida, Kishan Kumar ; Kalia, Nitin Pal ; Khatri, Dharmendra Kumar ; Mehra, Neelesh Kumar</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-datacite_primary_10_6084_m9_figshare_278782263</frbrgroupid><rsrctype>datasets</rsrctype><prefilter>datasets</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Biochemistry</topic><topic>Biotechnology</topic><topic>Cancer</topic><topic>Chemical Sciences not elsewhere classified</topic><topic>Developmental Biology</topic><topic>FOS: Clinical medicine</topic><topic>FOS: Health sciences</topic><topic>Immunology</topic><topic>Infectious Diseases</topic><topic>Medicine</topic><toplevel>online_resources</toplevel><creatorcontrib>Anuradha, Urati</creatorcontrib><creatorcontrib>Bhavana, Valamla</creatorcontrib><creatorcontrib>Chary, Padakanti Sandeep</creatorcontrib><creatorcontrib>Rajana, Naveen</creatorcontrib><creatorcontrib>Parida, Kishan Kumar</creatorcontrib><creatorcontrib>Kalia, Nitin Pal</creatorcontrib><creatorcontrib>Khatri, Dharmendra Kumar</creatorcontrib><creatorcontrib>Mehra, Neelesh Kumar</creatorcontrib><collection>DataCite (Open Access)</collection><collection>DataCite</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Anuradha, Urati</au><au>Bhavana, Valamla</au><au>Chary, Padakanti Sandeep</au><au>Rajana, Naveen</au><au>Parida, Kishan Kumar</au><au>Kalia, Nitin Pal</au><au>Khatri, Dharmendra Kumar</au><au>Mehra, Neelesh Kumar</au><format>book</format><genre>unknown</genre><ristype>DATA</ristype><title>Thymoquinone loaded nanoemulgel in streptozotocin induced diabetic wound</title><date>2024-11-21</date><risdate>2024</risdate><abstract><![CDATA[Aim: To treat diabetic wound healing with a novel Thymoquinone (TQ) loaded nanoformulation by using combination of essentials oils. Methods: TQ nanoemulsion (NE) was developed with seabuckthorn & lavender essential oils by phase inversion method and mixture design. Further, DIAGEL is obtained by incorporating NE into 1% carbopol®934. Furthermore, particle size, polydispersity index, thermodynamic stability studies, rheology, spreadability, drug content, in-vitro drug release, ex-vivo permeation, anti-oxidant assay, antimicrobial studies, angioirritance, HAT-CAM assay, in-vitro and in-vivo studies were determined. Results: NE has a particle size of 17.79 ± 0.61 nm, 0.206 ± 0.012 PDI & found to be thermodynamically stable. DIAGEL exhibited pseudoplastic behavior, sustained drug release, better permeation of TQ and a drug content of 98.54 ± 0.08%. DIAGEL stored for 6 months at room temperature and 2–8°C showed no degradation. Further, an improved angiogenesis, absence of angio-irritancy, remarkable antioxidant and antimicrobial activities against Candida albicans & S. aureus were observed. Cytotoxicity analysis revealed nearly 2.28 -folds higher IC50 value than drug solution. Furthermore, inflammatory mediators were reduced in DIAGEL treated animal groups. The histopathological studies confirmed skin healing with regeneration and granulation of tissue. Conclusion: The novel formulation has strong anti-inflammatory, angiogenesis, antioxidant and appreciable diabetic wound healing properties. Diabetic foot ulcer is a skin-inflammatory disease condition characterized by high blood glucose levels, & poor wound healing affecting mostly diabetic patients. Thymoquinone is a natural compound with anti-oxidant, anti-microbial, & anti-inflammatory, low solubility makes it challenging for formulation development. Nanoemulgel containing combination of oils with high solubility of thymoquinone can be an ideal one. We employed pseudo ternary phase diagram for selection of Smix ratio for developing annaoemlusion and to optimize the nanoemulsion we used here Randomized I-optimal mixture design, for characterization of nanoemulsion and nanoemulgel we used TEM, for gel properties we used here rheometer and texture analyzer. Developed nanoemulgel shows remarkable in-vitro antimicrobial activity against Candida albicans and S. aureus & also stimulating angiogenesis & negligible angioirritation by CAM assay. In-vitro cell lines studies were conducted on L929 cell to check the cytotoxicity of developed nanoformulation and also to check the cellular internalization, ROS, morphology, migration assay and apoptosis. In diabetic wound animal model nanoemulgel showed significant decreased levels of TNF-α, IL-6, MMP-9 and IL-1β. Histopathological studies also showed that absence of inflammatory cells, and granulation of tissue was seen. The amalgamation of these data strongly suggests that the nanoemulgel is a possible strategy for drug-delivery systems, with significant promising for the management of diabetic wound.]]></abstract><pub>Taylor & Francis</pub><doi>10.6084/m9.figshare.27878226</doi><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | DOI: 10.6084/m9.figshare.27878226 |
ispartof | |
issn | |
language | eng |
recordid | cdi_datacite_primary_10_6084_m9_figshare_27878226 |
source | DataCite |
subjects | Biochemistry Biotechnology Cancer Chemical Sciences not elsewhere classified Developmental Biology FOS: Clinical medicine FOS: Health sciences Immunology Infectious Diseases Medicine |
title | Thymoquinone loaded nanoemulgel in streptozotocin induced diabetic wound |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T09%3A02%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-datacite_PQ8&rft_val_fmt=info:ofi/fmt:kev:mtx:book&rft.genre=unknown&rft.au=Anuradha,%20Urati&rft.date=2024-11-21&rft_id=info:doi/10.6084/m9.figshare.27878226&rft_dat=%3Cdatacite_PQ8%3E10_6084_m9_figshare_27878226%3C/datacite_PQ8%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |